Tailoring NIR‐II Fluorescence and Photothermal Properties via Side‐Chain Engineering for Vascular Imaging and Image‐Guided Tumor Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yun-Yun Quan und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, C…. Hauptthemen laut MEDLINE: Photothermal Therapy, Optical Imaging, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Wenzhou Key Laboratory of Research and Transformation of Chinese Medicine.
Abstract (Originalsprache)
Second near‐infrared (NIR‐II, 1000–1700 nm) fluorescence imaging (FLI)‐guided photothermal therapy is a promising non‐invasive strategy for tumor theranostics. However, existing photothermal agents struggle to balance high photothermal conversion efficiency (PCE) with strong fluorescence quantum yield (QY). Herein, an alkoxyl side chain engineering strategy was proposed to construct a series of donor‐π bridge‐acceptor‐π bridge‐donor (D‐π‐A‐π‐D) structured organic photothermal agents ( TTQ1 ‐ TTQ6 ) enabling simultaneous NIR‐II FLI‐guided photothermal therapy. By introducing different alkoxyl side chains on triphenylamine donor or thiophene π‐bridge, the photophysical properties including aggregation‐induced emission (AIE) property, QY and PCE were regulated. TTQ2 NPs and TTQ6 NPs featured superior resolution and low background in in vivo NIR‐II fluorescence imaging of the mouse blood vessels with high signal‐to‐noise ratio. Four alkoxyl chains attached to the donor moiety enhanced the intramolecular donor‐acceptor interaction and effectively suppressed aggregation‐caused quenching (ACQ), enabling TTQ6 NPs to exhibit desirable NIR‐II fluorescence and a high PCE of 46.5%. Encouragingly, TTQ6 NPs could effectively ablate both subcutaneous and orthotopic breast tumors and stimulate adaptive immune responses, which collectively reduced the risk of tumor recurrence. This study illustrates the potential of alkoxyl side chain engineering strategy in developing advanced photothermal agents for NIR‐II FLI‐guided theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
- Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Xiaosheng Huang, Jing Zhang, Zu-Sheng Huang
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Wenzhou Key Laboratory of Research and Transformation of Chinese Medicine
Zitieren
APA
Quan, Y. Y., Zhang, Q., Feng, N., Zhang, J., Gong, H., Huang, X., Qiu, Y., Ye, X., Zhang, J., Li, Q., & Huang, Z. S. (2026). Tailoring NIR‐II Fluorescence and Photothermal Properties via Side‐Chain Engineering for Vascular Imaging and Image‐Guided Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71500
Vancouver
Quan YY, Zhang Q, Feng N, Zhang J, Gong H, Huang X, et al. Tailoring NIR‐II Fluorescence and Photothermal Properties via Side‐Chain Engineering for Vascular Imaging and Image‐Guided Tumor Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71500
BibTeX
@article{Quan2026,
author = {Quan, Yun-Yun and Zhang, Qin and Feng, Na and Zhang, Jin and Gong, Hangxin and Huang, Xiaosheng and Qiu, Yiting and Ye, Xiaoxia and Zhang, Jing and Li, Qingyun and Huang, Zu-Sheng},
title = {Tailoring NIR‐II Fluorescence and Photothermal Properties via Side‐Chain Engineering for Vascular Imaging and Image‐Guided Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71500}
}
EUVIMED